0001140361-13-012910.txt : 20130318
0001140361-13-012910.hdr.sgml : 20130318
20130318140838
ACCESSION NUMBER: 0001140361-13-012910
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130314
FILED AS OF DATE: 20130318
DATE AS OF CHANGE: 20130318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 13697071
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: (301) 795-1800
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc1.xml
FORM 4
X0306
4
2013-03-14
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380187
Abdun-Nabi Daniel
2273 RESEARCH BLVD. SUITE 400
ROCKVILLE
MD
20850
1
1
0
0
CEO & President
Common Stock
2013-03-14
4
F
0
2248
14.46
D
95211
D
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
/s/Jay G. Reilly, attorney-in-fact
2013-03-18